Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Cetrimonium
- Development stage
- Unknown
- Lead developer
- Daniels
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Administration
- Topical
01
Overview
Cetrimonium is a quaternary ammonium compound primarily used as a topical antiseptic and disinfectant. It acts as a surfactant and is effective against bacteria and fungi. Cetrimonium salts (such as cetrimonium chloride and cetrimonium bromide) are widely used in dermatological preparations for wound cleansing, seborrhoeic dermatitis treatment, and in cosmetic products like hair conditioners due to their ability to neutralize static electricity on hair. The mechanism of action involves disruption of microbial cell membranes through its surfactant properties[1][2][7][8].
- Brand names
- Xylonor
- Other names
- cetyltrimethylammoniumcetrimonium chloridecetrimonium bromideCTACCTAB
Beyond the preview
Go deeper on Cetrimonium.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Cetrimonium.